Picture 1 of 1
Gallery
Picture 1 of 1
Have one to sell?
Antipsychotic Trials in Schizophrenia by M.D. Stroup, T Scott, Dr.: New
US $147.95
ApproximatelyC $203.30
Condition:
Brand New
A new, unread, unused book in perfect condition with no missing or damaged pages. See the seller’s listing for full details.
- Buy It NowAntipsychotic Trials in Schizophrenia by M.D. Stroup, T Scott, Dr.: New
Oops! Looks like we're having trouble connecting to our server.
Refresh your browser window to try again.
Shipping:
Free Standard Shipping.
Located in: Sparks, Nevada, United States
Delivery:
Estimated between Mon, Aug 11 and Fri, Aug 15 to 94104
Returns:
30 days return. Buyer pays for return shipping. If you use an eBay shipping label, it will be deducted from your refund amount.
Payments:
Shop with confidence
Seller assumes all responsibility for this listing.
eBay item number:282828852821
Item specifics
- Condition
- Book Title
- Antipsychotic Trials in Schizophrenia
- Publication Date
- 2010-04-01
- Pages
- 330
- ISBN
- 9780521895330
About this product
Product Identifiers
Publisher
Cambridge University Press
ISBN-10
0521895332
ISBN-13
9780521895330
eBay Product ID (ePID)
78363286
Product Key Features
Number of Pages
330 Pages
Publication Name
Antipsychotic Trials in Schizophrenia : the Catie Project
Language
English
Subject
Psychiatry / Psychopharmacology, Psychopathology / Schizophrenia, Mental Health
Publication Year
2010
Type
Textbook
Subject Area
Psychology, Medical
Format
Hardcover
Dimensions
Item Height
6.3 in
Item Weight
24.7 Oz
Item Length
9.4 in
Item Width
0.8 in
Additional Product Features
Intended Audience
Scholarly & Professional
LCCN
2009-048606
Reviews
'This book is not just a reprint of all published CATIE papers - it takes us beyond the hype of the first publication by reminding us of the breadth and depth of the trial … This book will be of major interest to anyone involved in psychopharmacology. However, the richness of the use of social and cognitive end points means that there is a wealth of information for those who have no interest in antipsychotics but are interested in the lives and outcomes of people with schizophrenia.' The British Journal of Psychiatry, "Written and edited by the nationally recognized clinician-researchers involved in the study, this book is a welcome addition to the field....All of the important aspects of the study are discussed in detail, including the study design and protocol development process, statistical considerations, effectiveness and efficacy, cost-effectiveness and cost-benefit analysis, psychosocial functioning assessments, assessment of neurocognition, family outcomes, extrapyramidal side effects, metabolic side effects, substance use in schizophrenia, violence in schizophrenia, genetic investigations, human subject considerations, population pharmacokinetics, and implications for practice and policy. Each chapter concludes with relevant and timely citations of the scientific literature....This important and timely book contains the definitive archival results of this landmark study." --Doody's Review Service
Dewey Edition
22
Illustrated
Yes
Dewey Decimal
616.89/8061
Table Of Content
List of contributors; Acknowledgements; Introduction; 1. Study design and protocol development process T. Scott Stroup, Joseph P. McEvoy and Jeffrey A. Lieberman; 2. Statistical considerations Sonia M. Davis, Gary G. Koch, Robert A. Rosenheck and Vicki G. Davis; 3. Effectiveness and efficacy: staying on treatment and symptom reduction Joseph P. McEvoy, T. Scott Stroup and Jeffrey A. Lieberman; 4. Cost-effectiveness and cost-benefit analysis Robert A. Rosenheck and Douglas L. Leslie; 5. Psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study Marvin S. Swartz; 6. Neurocognition Richard S. E. Keefe; 7. Vocational outcomes Sandra G. Resnick and Robert A. Rosenheck; 8. Family outcomes Deborah A. Perlick, Richard Kaczynski and Robert A. Rosenheck; 9. Extrapyramidal side effects Stanley N. Caroff, Del D. Miller and Robert A. Rosenheck; 10. Metabolic side effects and risk of cardiovascular disease Jonathan M. Meyer, Donald C. Goff and Joseph P. McEvoy; 11. Substance use in persons with schizophrenia: incidence, baseline correlates, and effects on outcome Fred Reimherr, Marvin S. Swartz and John L. Olsen; 12. Violence in schizophrenia: prevalence, correlates, and treatment effectiveness Jeffrey Swanson and Richard Van Dorn; 13. Genetic investigations in the CATIE sample James J. Crowley and Patrick F. Sullivan; 14. Human subjects considerations T. Scott Stroup and Paul Appelbaum; 15. Population pharmacokinetics of antipsychotics Kristin L. Bigos, Robert R. Bies, Stephen R. Marder and Bruce G. Pollock; 16. Implications for research design and study implementation T. Scott Stroup and Jeffrey A. Lieberman; 17. Conclusion and implications for practice and policy Robert A. Rosenheck, T. Scott Stroup and Jeffrey A. Lieberman.
Synopsis
CATIE was the largest, longest and most comprehensive study of schizophrenia to date. This book presents the definitive archival results of this landmark study, with chapters focused on specific outcomes, setting the findings in a wider context. Essential reading for psychiatrists, psychiatric researchers, mental health policy makers and pharmaceutical companies., Antipsychotic medications are a key treatment for schizophrenia and sales of antipsychotic drugs approach $20 billion per year, with fierce marketing between the makers of the drugs. The U.S. National Institute of Mental Health sponsored the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project to provide independent information about the comparative effectiveness of medications. CATIE was the largest, longest and most comprehensive study of schizophrenia to date. Conducted under rigorous double-blind conditions, Antipsychotic Trials in Schizophrenia presents the definitive archival results of this landmark study. The core of the book consists of chapters focused on specific outcomes that set the CATIE findings in a wider context. Also included are chapters on the design, statistical analyses and implications for researchers, clinicians and policy makers. Psychiatrists, psychiatric researchers, mental health policy makers and those working in pharmaceutical companies will all find this to be essential reading.
LC Classification Number
RM333.5 .A58 2010
Item description from the seller
Seller feedback (514,209)
- m***m (2299)- Feedback left by buyer.Past 6 monthsVerified purchaseI’m thrilled with my recent purchase . The website was user-friendly, and the product descriptions were accurate. Customer service was prompt and helpful, answering all my questions. My order arrived quickly, well-packaged, and the product exceeded my expectations in quality. I’m impressed with the attention to detail and the overall experience. I’ll definitely shop here again and highly recommend from this seller to others. Thank you for a fantastic experience!
- a***n (45)- Feedback left by buyer.Past 6 monthsVerified purchaseMistakenly ordered a paperback that I thought was a hardcover, not sellers fault; it was described properly on the listing. Seller still processed a refund the day I went to return the item and let me keep the item anyway. A+++ service. Book arrived quickly in great condition and for a great price. Thank you so much! Amazing seller!
- n***c (95)- Feedback left by buyer.Past 6 monthsVerified purchaseseller was communicative about my shipment, media mail took a while and tracking wasn't updated frequently, but seller communicated to me very quickly on status. the item came new and wrapped as described, though the packaging in it was packed wasn't sturdy and falling apart when it got to me.
Seller feedback (514,209)
- m***m (2299)- Feedback left by buyer.Past 6 monthsVerified purchaseI’m thrilled with my recent purchase . The website was user-friendly, and the product descriptions were accurate. Customer service was prompt and helpful, answering all my questions. My order arrived quickly, well-packaged, and the product exceeded my expectations in quality. I’m impressed with the attention to detail and the overall experience. I’ll definitely shop here again and highly recommend from this seller to others. Thank you for a fantastic experience!
- a***n (45)- Feedback left by buyer.Past 6 monthsVerified purchaseMistakenly ordered a paperback that I thought was a hardcover, not sellers fault; it was described properly on the listing. Seller still processed a refund the day I went to return the item and let me keep the item anyway. A+++ service. Book arrived quickly in great condition and for a great price. Thank you so much! Amazing seller!
- n***c (95)- Feedback left by buyer.Past 6 monthsVerified purchaseseller was communicative about my shipment, media mail took a while and tracking wasn't updated frequently, but seller communicated to me very quickly on status. the item came new and wrapped as described, though the packaging in it was packed wasn't sturdy and falling apart when it got to me.